USPTO serial 97762122
PRISMATIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DANG, PETER T
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PRISMATIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JAMIE E STERNBERG
JAMIE E STERNBERG SAUNDERS & SILVERSTEIN LLP14 CEDAR STREETSUITE 224AMESBURY, MA 01913Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer programs using artificial intelligence for machine learning; downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer software, downloadable computer software platforms, downloadable mobile applications, and downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer programs using artificial intelligence for machine learning in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals | ABANDONED | — |
| 042 | Scientific research consulting services in the field of science, genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific research consulting; scientific research and development; scientific services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, oncological and diabetes-related data; genetic and tumor mapping for scientific and medical purposes; providing scientific research information; drug discovery services; providing an online searchable database in the fields of genetics, oncology, and diabetes for scientific research purposes; scientific research services, namely, analyzing scientific, genetic, oncological, biological and diabetes related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing scientific and clinical research and scientific consulting services by using machine learning and artificial intelligence technology in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; medical and scientific research and consulting, namely, conducting and designing clinical trials for others; scientific research and development services in the collection of information and data on biologicals for research purposes; providing on-line searchable genetic reference databases being collections of gene sequences for scientific research purposes; scientific research services, namely, disease modeling for research purposes; scientific analysis services, namely, services using computer algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer, diabetes, and other diseases; pharmaceutical drug development services; scientific research in the field of biomarker rankings; scientific research and development of pharmaceutical preparations; consulting services in the field of pharmaceutical research and development; providing temporary use of online non-downloadable software featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of science, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; providing a web site featuring temporary use of non-downloadable software featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of science, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; software design and development; computer software installation and maintenance; DNA analysis services for scientific research purposes; application service provider (ASP) featuring software using artificial intelligence for machine learning | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2024 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Mar 21, 2024 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Mar 21, 2024 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Mar 21, 2024 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Dec 21, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Sep 20, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 29, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 30, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 26, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 24, 2023 | NWAP | NEW APPLICATION ENTERED | — |